<DOC>
	<DOCNO>NCT00578526</DOCNO>
	<brief_summary>The purpose study find SU011248 work safe patient advance transitional cell carcinoma .</brief_summary>
	<brief_title>SU011248 Platinum-Refractory Urothelial Cancer Evaluation Trial</brief_title>
	<detailed_description>The study objective include determination antitumor effect SU011248 patient urothelial transitional cell carcinoma also determine toxicity tolerability SU011248 patient urothelial transitional cell carcinoma fail intolerant cisplatin-based chemotherapy . The primary endpoint study compare progression free survival 4 month patient receive SU011248 plus BSC versus patient receive placebo plus BSC The secondary endpoint compare objective response rate duration response patient receive SU011248 plus BSC versus patient receive placebo plus BSC , describe QOL safety profile SU011248 compare placebo describe overall survival patient receive SU011248 plus BSC versus patient receive placebo plus BSC</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Histologically/cytologically proven inoperable , metastatic recurrent transitional cell carcinoma urothelial tract Mixed histology predominant TCC allow . Failed , intolerant ineligible cisplatin base chemo Measurable Disease ( RECIST ) Not previously irradiate . Recovered previous acute treatment grade 1 ( CTCAE Vers . 3.0 ) No weight loss &gt; / 10 % within 28 day day 0 Adequate Organ Function Adenocarcinoma , squamous carcinoma histology without component transitional carcinoma . Small cell histology More one previous systemic chemo Excised metastasis without remain measureable disease Prior therapy angiogenesis inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>urothelial cancer</keyword>
	<keyword>target therapy</keyword>
	<keyword>antiangiogenesis therapy</keyword>
	<keyword>SU011248</keyword>
	<keyword>clinical trial</keyword>
</DOC>